Table 2.
All studies | Sensitivity analysisa | |||||||||
N |
Patients, n VTS vs. controlb |
WMD (95% CI)c | I2 | N |
Patients, n VTS vs. control |
WMD (95% CI) | I2 | Interpretation | QoEd | |
GA | 13 | 3780 vs. 49,763 | − 0.27 [− 0.44, − 0.11] | 72 | 10 | 3067 vs. 32,986 | − 0.34 [− 0.58, − 0.10] | 78 | Reductions are worse | Very lowf |
BW | 14 | 4719 vs. 54,819 | − 125.33 [− 162.93, − 87.73] | 73 | 10 | 3714 vs. 34,418 | − 141.07 [− 189.04, − 93.11] | 75 | Reductions are worse | Very lowf |
Events/patients, n VTS vs. control |
OR (95% CI) e |
Events/patients, n VTS vs. control |
OR (95% CI) | |||||||
PTB | 10 | 363/2722 vs. 4177/46810 | 1.48 [1.19, 1.85] | 70 | 7 | 276/2009 vs. 2633/30078 | 1.74 [1.28, 2.36] | 73 | Reductions are worse | Very lowf |
VPTB | 7 | 54/1993 vs. 382/29892 | 2.04 [1.43, 2.51] | 15 | 6 | 52/1909 vs. 367/29290 | 2.13 [1.49, 3.05] | 16 | Reductions are worse | Low |
LBW | 10 | 335/2932 vs. 2135/29532 | 1.78 [1.35, 2.33] | 76 | 8 | 314/2802 vs. 2046/28838 | 1.96 [1.42, 2.72] | 78 | Reductions are worse | Very lowf |
VLBW | 9 | 67/2835 vs. 261/28734 | 2.09 [1.39, 3.14] | 32 | 7 | 54/2705 vs. 231/28040 | 2.18 [1.42, 3.34] | 30 | Reductions are worse | Low |
SGA | 8 | 159/1393 vs. 1875/26742 | 1.81 [1.14, 2.87] | 77 | 6 | 74/679 vs. 420/9189 | 1.90 [0.96, 3.74] | 79 | Reductions are worse | Very lowf |
Congenital anomalies | 4 | 100/1110 vs. 827/11245 | 1.23 [0.88, 1.73] | 35 | 3 | 67/858 vs. 521/7407 | 1.01 [0.77, 1.32] | 0 | No difference | Very lowg |
Mortality | 3 | 13/955 vs. 44/9888 | 3.07 [1.63, 5.80] | 0 | 3 | 13/955 vs. 44/9888 | 3.07 [1.63, 5.80] | 0 | Reductions are worse | Lowg h |
GHD | 4 | 25/433 vs. 215/4130 | 1.20 [0.67, 2.18] | 35 | 4 | 25/433 vs. 215/4130 | 1.20 [0.67, 2.18] | 35 | No difference | Very lowg |
APH | 3 | 14/367 vs. 88/3835 | 1.54 [0.83, 2.88] | 0 | 3 | 14/367 vs. 88/3835 | 1.54 [0.83, 2.88] | 0 | No difference | Very lowg |
N, no. of studies; OR, odds ratio; WMD, weight mean difference; CI, confidence interval; GA, gestational age at delivery; BW, birth weight; PTB, preterm birth (< 37 weeks); VPTB, very preterm birth (< 32 weeks); LBW, low birth weight (< 2.5 kg); VLBW, very low birth weight (< 1.5 kg); SGA, small for gestational age, APH, antepartum hemorrhage; GHD, gestational hypertensive diseases
aSensitivity analysis restricted eligibility to studies deemed to be of high quality
bThe number of participants, events, and proportions considered all women included in these studies
cA WMD < 0 suggest an significantly lower of this outcome in singleton with VTS compared with original singleton
dAll outcomes were downgraded two levels because evidence come from observational studies
eA OR > 1.0 suggest an increased risk of this outcome in singleton with VTS compared with original singleton
fDowngraded one level because of inconsistency
gDowngraded one level because of imprecision
hUpgraded one level because of large effects